Pay in 4 interest-free payments of $6.57 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
no large phase 3 trials have been completed, and the compound is not approved for any clinical use
Anti-Aging IV Therapy Korea Medical-Grade IV Infusions at RE:BERRY Myeongdong Seoul Korean clinics perform 56.6% of all foreign patient dermatology procedures (KHIDI 2025), and RE:BERRY Myeongdong delivers anti-aging IV therapy in Korea with physician-supervised NAD+, glutathione, and autologous blood protocols in a single 40-60 minute session
Ipamorelin is not FDA-approved as a prescription drug in the U.S., so product quality and labeling accuracy can be a major concern outside legitimate medical oversight
Contraindications Based on mechanisms and theoretical considerations, BPC-157 may not be appropriate for: Individuals with active cancer Pregnant or breastfeeding women Those with uncontrolled cardiovascular conditions People taking anticoagulant medications (effects on bleeding unknown) Individuals with autoimmune conditions (immune modulation effects unclear) Quality and Purity Concerns Perhaps the most significant safety concern involves product quality
Gao Y, Jiao Y, Gong X, Liu J, Xiao H, Zheng Q
Histopathological analysis The solid tumor and major organs were harvested from tumor-bearing mice for histological observation by standard H&E and immunofluorescence staining
